4.6 Article

Precancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation

Journal

PLOS ONE
Volume 2, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0000293

Keywords

-

Funding

  1. Department of Pathology
  2. Ohio State University (OSU)
  3. Strategy Initiative [2005/2006]
  4. American Cancer Society [IRG-112367]
  5. Immunology Program
  6. Davis/Bremer Medical Research
  7. National Cancer Institute [CA095512]
  8. United States Army
  9. Chronic Myelogenous Leukemia (CML) Research Program [DAMD17-03-1-0184]
  10. National Institute of Child and Human Development [HD42012]

Ask authors/readers for more resources

Cancer stem cells (CSCs) have been identified in hematopoietic and solid tumors. However, their precursors-namely, precancerous stem cells (pCSCs) -have not been characterized. Here we experimentally define the pCSCs that have the potential for both benign and malignant differentiation, depending on environmental cues. While clonal pCSCs can develop into various types of tissue cells in immunocompetent mice without developing into cancer, they often develop, however, into leukemic or solid cancers composed of various types of cancer cells in immunodeficient mice. The progress of the pCSCs to cancers is associated with the up-regulation of c-kit and Sca-1, as well as with lineage markers. Mechanistically, the pCSCs are regulated by the PIWI/AGO family gene called piwil2. Our results provide clear evidence that a single clone of pCSCs has the potential for both benign and malignant differentiation, depending on the environmental cues. We anticipate pCSCs to be a novel target for the early detection, prevention, and therapy of cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available